Invitae Corporation
NVTA
Peringkat dalam Saham
#35702
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Harga Saham
$0.016
Terakhir disinkronkan: 2024-03-11
Kapitalisasi Pasar
$3.27M
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
5,233.33%
Negara
US
Perdagangan Invitae Corporation (NVTA)
Kategori
Healthcare
Riwayat harga saham Invitae Corporation (NVTA)
Harga penutupan tertinggi: $0.00 pada 2024-08-01
Harga penutupan terendah: $19.17 pada 2015-02-01
Harga penutupan terendah: $19.17 pada 2015-02-01
Riwayat harga saham Invitae Corporation dari 2015 hingga 2026
Performa harga saham tahunan
| Tahun | Performa |
|---|---|
| 2024 | -99.95% |
| 2023 | -71.56% |
| 2022 | -86.50% |
| 2021 | -67.85% |
| 2020 | 194.07% |
| 2019 | 47.18% |
| 2018 | 31.94% |
| 2017 | 20.96% |
| 2016 | -6.63% |
| 2015 | 0.00% |
Harga saham perusahaan atau pesaing serupa
| Perusahaan | Harga saham | Perubahan 1th% | Negara |
|---|---|---|---|
| $676.64 | 19.29% |
US
|
|
| $229.46 | 5.21% |
US
|
|
| $390.84 | 107.87% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $172.39 | 18.18% |
US
|
